Frequency of Post Endoscopic Retrograde Cholangiopacreatography Pancreatitis in Patients with Pancreatic Disease
DOI:
https://doi.org/10.63682/jns.v14i32S.8668Keywords:
Endoscopic Retrograde Cholangiopancreatography, Pancreatitis, Pancreatic DiseaseAbstract
Endoscopic retrograde cholangiopancreatography (ERCP) is a technique that combines the use of endoscopy and fluoroscopy to diagnose and treat certain problems of the biliary or pancreatic ductal systems. Post-ERCP pancreatitis (PEP) is diagnosed when patients develop signs and symptoms of acute pancreatitis in addition to elevation of pancreatic enzymes.
Objective: To determine the frequency of post ERCP in patients undergoing endoscopic retrograde cholangiopancreatography for pancreatic disease
Methodology: This descriptive case series study was conducted at the Gastroenterology Unit of Lahore General Hospital, Lahore, over a duration of six months following the approval of the synopsis, from May 2023 to June 2024. Patients were prepared for the procedure by overnight fasting and received antibiotic prophylaxis with an injection of Ceftriaxone 1 gram. The ERCP procedure was performed under regional anesthesia by a single senior gastroenterologist with a minimum of four years of residency experience. Post-ERCP outcomes were carefully documented. All collected data were entered and analyzed using SPSS version 20.
Results: The mean age of patients was 37.19±10.54 years. Abdominal pain was observed in 44(14.33%) patients and PEP was found in 44(14.33%) patients.
Conclusion: The frequency of PEP was 14.33% in patients with pancreatic disease
Downloads
Metrics
References
Puig I, Calvet X, Baylina M, Isava Á, Sort P, Llaó J, et al. How and when should NSAIDs be used for preventing post-ERCP pancreatitis? A systematic review and meta-analysis. PLoS One. 2014;9(3):e92922. doi: 10.1371/journal.pone.0092922.
Parsi MA. NSAIDs for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: Ready for prime time? World Journal of Gastroenterology: WJG.2012;18(30):3936-7.doi10.3748/wjg.v18.i30.3936
Kwon C-I, Song SH, Hahm KB, Ko KH. Unusual complications related to endoscopic retrograde cholangiopancreatography and its endoscopic treatment. Clinical endoscopy. 2013;46(3):251-9. doi: 10.5946/ce.2013.46.3.251
Kochar B, Akshintala VS, Afghani E, Elmunzer BJ, Kim KJ, Lennon AM, et al. Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointestinal endoscopy. 2015;81(1):143-9. e9. doi: 10.1016/j.gie.2014.06.045.
Christoforidis E, Goulimaris I, Kanellos I, Tsalis K, Demetriades C, Betsis D. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors. Endoscopy. 2002;34(04):286-92. doi: 10.1055/s-2002-23630.
Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointestinal endoscopy. 2001;54(4):425-34. doi: 10.1067/mge.2001.117550.
Leghari A, Ghazanfar S, Qureshi S, Taj MA, Niaz SK, Quraishy MS. Frequency and risk factors in the post-ERCP pancreatitis in a tertiary care centre. J Coll Phys Surg Pak. 2013;23:620-4. Available from https://www.jcpsp.pk/archive/2013/Sep2013/03.pdf
Thaker AM, Mosko JD, Berzin TM. Post-endoscopic retrograde cholangiopancreatography pancreatitis. Gastroenterol Rep. 2015;3(1):32-40. doi: 10.1093/gastro/gou083. doi: 10.1093/gastro/gou083
Jeurnink S, Siersema P, Steyerberg E, Dees J, Poley JW, Haringsma J, et al. Predictors of complications after endoscopic retrograde cholangiopancreatography: a prognostic model for early discharge. Surgical endoscopy. 2011;25(9):2892-900. doi: 10.1007/s00464-011-1638-9.
Yang D, Draganov PV. Indomethacin for post-endoscopic retrograde cholangiopancreatography pancreatitis prophylaxis: Is it the magic bullet? World Journal of Gastroenterology: WJG. 2012;18(31):4082-5 doi: 10.3748/wjg.v18.i31.4082
Pande H, Thuluvath PJ. Pharmacological prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Drugs. 2003;63(17):1799-812. doi: 10.2165/00003495-200363170-00003.
El Nakeeb A, El Hanafy E, Salah T, Atef E, Hamed H, Sultan AM, et al. Post-endoscopic retrograde cholangiopancreatography pancreatitis: Risk factors and predictors of severity. World journal of gastrointestinal endoscopy. 2016;8(19):709-15. doi: 10.4253/wjge.v8.i19.709
Katsinelos P, Lazaraki G, Chatzimavroudis G, Gkagkalis S, Vasiliadis I, Papaeuthimiou A, et al. Risk factors for therapeutic ERCP-related complications: an analysis of 2,715 cases performed by a single endoscopist. Annals of gastroenterology. 2014;27(1):65-75 Available from https://pubmed.ncbi.nlm.nih.gov/24714755/
Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, et al. Complications of endoscopic biliary sphincterotomy. New England Journal of Medicine. 1996;335(13):909-18. doi: 10.1056/NEJM199609263351301.
Thaker AM, Mosko JD, Berzin TM. Post-endoscopic retrograde cholangiopancreatography pancreatitis. Gastroenterology report. 2014;3(1):32-40. doi: 10.1093/gastro/gou083.
Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointestinal endoscopy. 1998;48(1):1-10. doi: 10.1016/s0016-5107(98)70121-x
Cotton P, Lehman G, Vennes J, Geenen J, Russell R, Meyers W, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointestinal endoscopy. 1991;37(3):383-93. doi: 10.1016/s0016-5107(91)70740-2.
Freeman ML. Adverse outcomes of ERCP. Gastrointestinal endoscopy. 2002;56(6):S273-S82.. doi: 10.1067/mge.2002.129028.
Cotton PB, Garrow DA, Gallagher J, Romagnuolo J. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointestinal endoscopy. 2009;70(1):80-8. doi: 10.1016/j.gie.2008.10.039.
Elmunzer BJ, Scheiman JM, Lehman GA, Chak A, Mosler P, Higgins PD, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. New England Journal of Medicine. 2012;366(15):1414-22. doi: 10.1056/NEJMoa1111103.
Pahk A, Rigaux J, Poreddy V, Smith J, Al-Kawas F. Prophylactic pancreatic stents: does size matter? A comparison of 4-Fr and 5-Fr stents in reference to post-ERCP pancreatitis and migration rate. Digestive diseases and sciences. 2011;56(10):3058-64. doi: 10.1007/s10620-011-1695-x.
Cheng C-L, Sherman S, Watkins JL, Barnett J, Freeman M, Geenen J, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. The American journal of gastroenterology. 2006;101(1):139-47. doi: 10.1111/j.1572-0241.2006.00380.x.
Vandervoort J, Soetikno RM, Tham TC, Wong RC, Ferrari AP, Montes H, et al. Risk factors for complications after performance of ERCP. Gastrointestinal endoscopy. 2002;56(5):652-6. doi: 10.1067/mge.2002.129086
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
